Your browser doesn't support javascript.
loading
SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry.
Gonzalez-Cao, Maria; Puertolas, Teresa; Martinez-Vila, Clara; Carrera, Cristina; Maldonado Seral, Cayetana; Rodríguez-Jiménez, Pedro; Sequero, Silvia; Cerezuela-Fuentes, Pablo; Feltes Ochoa, Rosa; Muñoz, Eva; Antoñanzas Basa, Mónica; Martín-Liberal, Juan; Soria, Ainara; Francisco Rodriguez Moreno, Juan; Marquez-Rodas, Ivan; Lopez Criado, Pilar; Luis Manzano, José; Lopez-Castro, Rafael; Ayala de Miguel, Pablo; Villalobos, Laura; Martin Algarra, Salvador; Gonzalez-Barrallo, Ines; Boada, Aram; García Castaño, Almudena; Puig, Susana; Crespo, Guillermo; Luna Fra, Pablo; Aguayo Zamora, Cristina; Feito Rodríguez, Marta; Valles, Lara; Drozdowskyj, Ana; Gardeazabal, Jesús; Antonio Fernandez-Morales, Luis; Rodrigo, Alberto; Cruz, Raquel; Yelamos, Oriol; Rubio, Belen; Mujica, Karmele; Provencio, Mariano; Berrocal, Alfonso.
Afiliación
  • Gonzalez-Cao M; Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, C/Sabino Arana, 5, 080028, Barcelona, Spain. mgonzalezcao@oncorosell.com.
  • Puertolas T; Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Martinez-Vila C; Fundación Althaia, Xarxa Assistencial Universitària de Manresa, Barcelona, Spain.
  • Carrera C; Dermatology Department, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melanoma Group IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Maldonado Seral C; Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Rodríguez-Jiménez P; Dermatology Department, Hospital Universitario la Princesa, Madrid, Spain.
  • Sequero S; Medical Oncology Department, Hospital San Cecilio, Granada, Spain.
  • Cerezuela-Fuentes P; Medical Oncology Department, Hospital Clinico Universitario Virgen Arrixaca, Murcia, Spain.
  • Feltes Ochoa R; Hospital Universitario la Paz, Madrid, Spain.
  • Muñoz E; Medical Oncology Department. Hospital, Universitari Vall d'Hebron, Barcelona, Spain.
  • Antoñanzas Basa M; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Martín-Liberal J; Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain.
  • Soria A; Medical Oncology Department, Catalan Institute of Oncology (ICO) Hospitalet, Barcelona, Spain.
  • Francisco Rodriguez Moreno J; Medical Oncology Department, Hospital Ramon y Cajal, Madrid, Spain.
  • Marquez-Rodas I; Medical Oncology Department, Centro Integral Oncologico HM Clara Campal, Madrid, Spain.
  • Lopez Criado P; Medical Oncology Department, Hospital General Universitario Gregorio Marañon and CIBERONC, Madrid, Spain.
  • Luis Manzano J; Medical Oncology Department, Hospital MD Anderson, Madrid, Spain.
  • Lopez-Castro R; Medical Oncology Department, Catalonian Institute of Oncology (ICO-Badalona), Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Barcelona, Spain.
  • Ayala de Miguel P; Medical Oncology Department, HCU Valladolid, Valladolid, Spain.
  • Villalobos L; Hospital San Pedro de Alcántara, Cáceres, Spain.
  • Martin Algarra S; Hospital Principe de Asturias, Alcala de Henares, Spain.
  • Gonzalez-Barrallo I; Medical Oncology Department, Clinica Universitaria de Navarra, Pamplona, Spain.
  • Boada A; Hospital Clinico de Valencia, Valencia, Spain.
  • García Castaño A; Dermatology Department, Hospital Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Barcelona, Spain.
  • Puig S; Medical Oncology Department, Hospital Marqués de Valdecilla, Santander, Spain.
  • Crespo G; Dermatology Department, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Melanoma Group IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Luna Fra P; Hospital Universitario de Burgos, Burgos, Spain.
  • Aguayo Zamora C; Hospital Son Espases, Mallorca, Spain.
  • Feito Rodríguez M; Hospital Universitario Infanta Sofía, Madrid, Spain.
  • Valles L; Hospital Universitario la Paz, Madrid, Spain.
  • Drozdowskyj A; Hospital General de Villalba, Madrid, Spain.
  • Gardeazabal J; Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, C/Sabino Arana, 5, 080028, Barcelona, Spain.
  • Antonio Fernandez-Morales L; Hospital de Cruces, Bilbao, Spain.
  • Rodrigo A; Hospital Parc Tauli, Sabadell, Spain.
  • Cruz R; Hospital Arnau de Vilanova, Lleida, Spain.
  • Yelamos O; Hospital Universitario Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.
  • Rubio B; Dermatology Department, Hospital Sant Pau, Barcelona, Spain.
  • Mujica K; Oncology Department, Hospital Quiron, Madrid, Spain.
  • Provencio M; Hospital Donostia, Donostia, Spain.
  • Berrocal A; Hospital Puerta de Hierro, Madrid, Spain.
Clin Transl Oncol ; 25(3): 768-775, 2023 Mar.
Article en En | MEDLINE | ID: mdl-36566266
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus / COVID-19 / Melanoma Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Año: 2023 Tipo del documento: Article País de afiliación: España Pais de publicación: Italia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus / COVID-19 / Melanoma Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Aged / Aged80 / Child / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Año: 2023 Tipo del documento: Article País de afiliación: España Pais de publicación: Italia